AHA: Ablation Better Than Meds for Initial A-Fib Treatment
WEDNESDAY, Nov. 25, 2020 -- Cryoballoon ablation is superior to drug therapy as an initial treatment for the prevention of atrial arrhythmia recurrence in patients with paroxysmal atrial fibrillation, according to a study published online Nov. 16 in the New England Journal of Medicine to coincide with the American Heart Association Scientific Sessions 2020, held virtually from Nov. 13 to 17.
Oussama M. Wazni, M.D., from the Cleveland Clinic, and colleagues assessed the safety and efficacy of cryoballoon ablation as initial first-line therapy for patients with symptomatic paroxysmal atrial fibrillation. The analysis included treatment-naïve patients who were randomly assigned to either treatment with antiarrhythmic drugs (99 individuals) or pulmonary vein isolation with a cryoballoon (104 individuals).
The researchers report that in the ablation group, 97 percent of patients achieved initial success with the procedure. At 12 months, the percentage of patients with treatment success was 74.6 percent in the ablation group versus 45.0 percent in the drug-therapy group. Procedure-related and cryoballoon system-related serious adverse events occurred in 1.9 percent of patients in the ablation group.
"Earlier intervention with ablation may keep patients free from atrial fibrillation longer and prevent the disease from progressing into more persistent atrial fibrillation," Wazni said in a statement.
Several authors disclosed financial ties to Medtronic, which funded the study.
© 2021 HealthDay. All rights reserved.
Posted: November 2020
Read this next
WEDNESDAY, Jan. 13, 2021 -- Alcohol consumption, even at a level of one drink per day, is associated with an increased risk for atrial fibrillation (AF), according to a study...
THURSDAY, Nov. 19, 2020 -- The volume of transcatheter aortic valve replacement (TAVR) procedures in the United States increased from 2011 to 2019, exceeding surgical aortic valve...
MONDAY, Nov. 16, 2020 -- For adults with atrial fibrillation, warfarin is associated with an increased risk for knee and hip replacements for osteoarthritis (OA), according to a...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.